Skip to content

Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00285441
Enrollment
60
Registered
2006-02-02
Start date
2005-11-30
Completion date
2008-09-30
Last updated
2006-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections, Rheumatoid Arthritis, Tuberculosis

Keywords

HIV

Brief summary

The purpose of this study is to identify differences in TB specific immune responses among immunosuppressed patients latently infected with TB and patients with active TB.

Detailed description

Immunosuppressed patients latently infected with TB are at higher risk of developing active TB than patients with normal immune functions. Especially two patient categories are at risk: HIV positives and patients receiving TNF-a blocking medication. Existing methods of diagnosis and surveillance of latent TB infection can not identify who will develop active TB and who can control the infection. There is a need for better understanding of TB specific immune functions,as we believe deficient TB specific immune reactions is a key in reactivation of latent TB infection. In this study we follow groups of latent TB infected patients with either rheumatoid arthritis or HIV. We follow the patients during treatment with TNF-a blocking medication, HAART treatment or prophylactic TB medication. Results are correlated to patients with active TB, latent TB and healthy controls.

Interventions

None listed

Sponsors

Copenhagen Hospital Corporation
CollaboratorOTHER
The Danish Rheumatism Association
CollaboratorOTHER
Danish Lung Association
CollaboratorOTHER
Hvidovre University Hospital
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Latent TB infection + rheumatid arthritis * Latent TB infection + HIV * Active TB

Exclusion criteria

* Age \< 18yrs * Pregnancy * Patients not able to understand the given information

Countries

Denmark

Contacts

Primary ContactMorten Ruhwald, MD
mruhwald@mail.dk+45 36323632
Backup ContactPernille Ravn, MD, Ph.d.
pravn@dadlnet.dk+45 36323632

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026